Europe Micro Invasive Glaucoma Surgery Migs Devices Market
Tamanho do mercado em biliões de dólares
CAGR :
% 
 Período de previsão |
2024 –2030 |
 Tamanho do mercado (ano base ) | |
 Tamanho do mercado ( Ano de previsão) | USD 1,738.15 |
 CAGR |
% |
| Principais participantes do mercado |
>Mercado europeu de dispositivos para cirurgia microinvasiva do glaucoma (MIGS), por tipo de produto (derivação MIGS, stent MIGS, trabectome, lâmina dupla Kahook, derivação de tubo, micro-implantes, microcateteres e outros), alvo (malha trabecular, espaço supracoroidal , filtração subconjuntival , redução da produção aquosa e outras), tipo de cirurgia (glaucoma em conjunto com catarata, glaucoma autónomo), tipo de glaucoma (glaucoma de ângulo aberto, glaucoma agudo de ângulo fechado, glaucoma de tensão normal, glaucoma secundário, glaucoma pigmentar e glaucoma congénito) , Utilizador Final (Departamento de Ambulatório do Hospital (HOPD), Clínicas Oftalmológicas, Centros de Cirurgia Ambulatória (ASCS) e Outros), Canal de Distribuição (Concurso Directo, Vendas a Retalho e Outros) - Tendências do Sector e Previsão para 2030.
Análise e insights do mercado de dispositivos para cirurgia microinvasiva do glaucoma na Europa (MIGS)
A cirurgia microinvasiva do glaucoma (MIGS) é utilizada para tratar o glaucoma de ângulo aberto. Inicialmente, para tratar o OAG, foram administrados medicamentos que reduziam a produção de humor aquoso ou aumentavam o fluxo de humor aquoso. Para a OAG ligeira a moderada, tradicionalmente, era realizado tratamento farmacológico e laser. Com o advento dos procedimentos de cirurgia microinvasiva do glaucoma (MIGS), foram criadas novas opções para aqueles que não estão aptos para a cirurgia convencional. Espera-se que o aumento da população de geriatria e o aumento das iniciativas governamentais para a prevenção da cegueira impulsionem o mercado. A rápida transição da medicação para o glaucoma para cirurgias de glaucoma minimamente invasivas pode estar a criar oportunidades para o fabricante de dispositivos MIGS.
A Data Bridge Market Research analisa que o mercado europeu de dispositivos para cirurgia microinvasiva do glaucoma (MIGS) deverá atingir o valor de 1.738,15 milhões de dólares até 2030, com um CAGR de 29,7% durante o período de previsão 2023-2030 . O shunt MIGS é responsável pelo maior segmento de tipo de produto do mercado devido à crescente procura de dispositivos cirúrgicos minimamente invasivos.
|
Métrica de relatório |
Detalhes |
|
Período de previsão |
2023 a 2030 |
|
Ano base |
2022 |
|
Anos históricos |
2021 (personalizável para 2015-2020) |
|
Unidades Quantitativas |
Receita em milhões de dólares, volumes em unidades, preços em dólares |
|
Segmentos cobertos |
Tipo de Produto (Shunt MIGS, Stent MIGS, Trabectome, Kahook Dual Blade, Tube Shunt, Micro-Implantes, Micro Cateteres e Outros), Alvo (Malha Trabecular, Espaço Supracoroidal, Filtração Subconjuntival, Redução da Produção Aquosa e Outros), Tipo de Cirurgia (Glaucoma em conjunto com catarata, glaucoma autónomo), tipo de glaucoma (glaucoma de ângulo aberto, glaucoma agudo de ângulo fechado, glaucoma de tensão normal, glaucoma secundário, glaucoma pigmentar e glaucoma congénito), utilizador final (departamento de doentes externos do hospitalar (HOPD), oftalmologia Clínicas, Centros Cirúrgicos Ambulatório (ASCS) e Outros), Canal de Distribuição (Concurso Directo, Venda a Retalho e Outros) |
|
Países abrangidos |
Germany, U.K., France, Italy, Russia, Spain, Turkey, Switzerland, Netherlands, Belgium, Denmark, Poland, Sweden, Norway, Finland and Rest of Europe |
|
Market Players Covered |
Glaukos corporation, AbbVie Inc., Alcon, Johnson & Johnson Vision Care Inc., Sight sciences, Inc., Santen Pharmaceutical Co., Ltd, iSTAR Medical, BVI, Nova Eye Medical, Lumenis Be Ltd, Inami & Co., Ltd, Oertli Instrumente AG, Lumibird |
Europe Micro Invasive Glaucoma Surgery (MIGS) Devices Market Definition
MIGS stands for micro invasive glaucoma surgery, which helps treat glaucoma. It is a breakthrough technology in the treatment of mild to moderate glaucoma. It is an alternative to the medications given earlier, and it also prevents the complications of conventional surgery. These procedures are used to lower the intra-ocular pressure of the eye to avoid damage to the optic nerve. These procedures are safer and have a very rapid recovery time compared to conventional surgery. The various MIGS devices implanted are shunts and stents to lower the IOP.
The growing incidences of eye diseases, rising demand for micro invasive glaucoma surgery, rising number of players in the market, and novel product launches are also propelling the growth of the Europe micro invasive surgery device market (MIGS).
Europe Micro Invasive Glaucoma Surgery (MIGS) Devices Market Dynamics
This section deals with understanding the market drivers, advantages, opportunities, restraints, and challenges. All of this is discussed in detail below:
Drivers
- Growth in Popularity of Minimally Invasive Surgery
Glaucoma is the second most common cause of blindness. According to WHO, 4.5 million people are blind because of glaucoma. The only effective treatment of glaucoma is to lower intra-ocular pressure so that there is no damage to the optic nerve. Earlier, there were only three ways to treat glaucoma; medications, laser therapy, and in severe cases, incisional surgeries. The medicines have some drawbacks, like patient adherence and ocular toxicity. Also, these are costly and are only available to some in developing countries. Laser therapies, though, are non-invasive. They lose their effectiveness over the period. Incisional surgeries are the most effective treatment to lower intraocular pressure. Still, they can fail due to scarring, decreased quality of life due to bleb-related foreign body sensation, induced astigmatism, and secondary cataracts.
MIGS provide provides safer, less invasive means of reducing intraocular pressure. Also, they reduce the dependencies on medication. They have quicker recovery time and modest results compared to incisional surgeries. Hence, surgeons and patients are increasingly adopting these micro-invasive surgeries. Therefore, the growing popularity of minimally invasive surgery is expected to drive the market growth.
- Rise in Incidence of Glaucoma
A causa da cegueira global irreversível é principalmente o glaucoma. O glaucoma é um grupo de doenças oculares que apresentam poucos ou nenhuns sintomas na fase inicial, mas que posteriormente levam a danos nos nervos óticos, o que pode levar à perda de visão ou cegueira. A prevalência do glaucoma tem vindo a aumentar.
Melhorar a qualidade de vida é fundamental para reduzir a carga do glaucoma, uma vez que este apresenta vários fatores de risco graves. É necessário mudar para técnicas revolucionárias, como a cirurgia microinvasiva do glaucoma, para a ultrapassar numa fase inicial. Portanto, isto cria uma procura por dispositivos MIGS; assim, espera-se que uma incidência crescente de glaucoma atue como um impulsionador do mercado.
Oportunidade
-
Introdução de Produto Tecnológico Avançado
O glaucoma é uma doença ocular grave que pode levar à perda de visão se não for controlada. Geralmente não leva à cegueira, pois pode ser controlada por tratamentos modernos e muitas opções para prevenir danos maiores. Com o aumento dos desenvolvimentos científicos, houve uma mudança revolucionária no tratamento do glaucoma. Com o advento da cirurgia microinvasiva do glaucoma, há uma mudança de paradigma na medicina, pois pode ajudar no tratamento do glaucoma numa fase inicial e evitar a dependência de cirurgias de filtração como a trabeculectomia. Isto também supera os riscos associados a estas cirurgias incisionais. Existem vários avanços no tratamento do glaucoma com MIGS.
Estas novas tecnologias são mais seguras e proporcionam resultados modestos a bons. Por isso, estes estão a ser cada vez mais adotados por pacientes e cirurgiões. Isto cria uma oportunidade para os fabricantes produzirem dispositivos tecnologicamente mais avançados. Assim, a introdução de produtos tecnologicamente avançados pode funcionar como uma oportunidade para o mercado.
Restrições/ Desafios
-
Cenário de reembolso inadequado
A visão está em risco com o glaucoma; muitas pessoas continuam a perder a visão diariamente com esta doença. Os doentes com glaucoma ligeiro a moderado receberam terapêutica médica convencional e as opções cirúrgicas foram limitadas a pessoas com glaucoma grave. No entanto, existe uma mudança de paradigma no tratamento do glaucoma com a introdução dos dispositivos MIGS. Os danos avançados no glaucoma podem ser evitados realizando uma cirurgia microinvasiva do glaucoma numa fase inicial.
Os cirurgiões não preferem utilizar dispositivos MIGS porque os reembolsos são muito baixos. Quando as pessoas não são pagas por ele, deixam de o utilizar e, em última análise, a sua produção é interrompida. Embora os dispositivos MIGS estejam a revolucionar o tratamento do glaucoma, a aprovação e o pagamento destes dispositivos pelas seguradoras são vistos como um obstáculo. Assim, espera-se que os reembolsos deficientes sejam considerados uma restrição para o mercado.
- Falta de profissionais qualificados e com conhecimentos adequados
A cirurgia intraocular é uma tarefa muito complexa, uma vez que o trabalho deve ser realizado em espaços mais pequenos adjacentes a estruturas suscetíveis, onde qualquer erro pode levar à perda permanente da visão. Isto torna a presença de profissionais qualificados uma necessidade para a cirurgia. A realização de MIGS requer um nível de habilidade ainda mais elevado porque envolve o tratamento, o trabalho em espaços mais pequenos e sensíveis dentro do olho e a aprendizagem de uma nova habilidade propriocetiva, ou seja, a visualização gonioscópica cirúrgica intraoperatória do ângulo. Embora a presença de profissionais qualificados seja altamente necessária, existe uma escassez aguda de cirurgiões formados nos países em desenvolvimento.
Mais ainda, observa-se uma escassez de profissionais especializados em cirurgia oftalmológica em todo o mundo, tornando-se um problema grave no tratamento do glaucoma. Como o número de cirurgiões é escasso, o número de procedimentos cirúrgicos será deficiente; portanto, este é visto como um obstáculo. Assim, um elevado nível de dependência do mercado na disponibilidade de profissionais qualificados com conhecimentos adequados pode desafiar o mercado.
Desenvolvimento recente
- Em fevereiro de 2022, a Santen lançará uma plataforma inovadora e interativa de educação médica para profissionais de saúde (HCPs). Dá aos oftalmologistas acesso a uma aprendizagem personalizada e de alta qualidade ao seu próprio ritmo. Isto ajudará a aumentar a consciencialização entre os profissionais de saúde e levará a um melhor tratamento e crescimento para a empresa
Âmbito do mercado de dispositivos para cirurgia microinvasiva do glaucoma na Europa (MIGS)
O mercado europeu de dispositivos para cirurgia microinvasiva do glaucoma (MIGS) está categorizado em seis segmentos por tipo de produto, alvo, tipo de cirurgia, tipo de glaucoma, utilizador final e canal de distribuição. O crescimento entre segmentos ajuda-o a analisar os nichos de crescimento e as estratégias para abordar o mercado e determinar as suas principais áreas de aplicação e a diferença nos seus mercados-alvo.
Tipo de produto
- Stents Migs
- Manobras Migs
- Trabectoma
- Lâmina Dupla Kahook
- Derivação de tubo
- Microimplantes
- Micro Cateteres
- Outros
Com base no tipo de produto, o mercado europeu de dispositivos para cirurgia microinvasiva do glaucoma (MIGS) está segmentado em shunts MIGS, stents MIGS, trabectomia, lâmina dupla kahook, shunt de tubo, micro implantes, micro cateteres e outros.
Objetivo
- Malha Trabecular
- Espaço Supracoroidal
- Filtragem Subconjuntival
- Reduzindo a produção aquosa
- Outros
Com base no alvo, o mercado europeu de dispositivos para cirurgia microinvasiva do glaucoma (migs) está segmentado em malha trabecular, espaço supracoroidal, filtração subconjuntival, redução da produção aquosa e outros.
Tipo de cirurgia
- Glaucoma em conjunto com catarata
- Glaucoma autónomo
Com base no tipo de cirurgia, o mercado europeu de dispositivos para cirurgia microinvasiva do glaucoma (MIGS) está segmentado em glaucoma em conjunto com catarata e glaucoma autónomo.
Tipo Glaucoma
- Glaucoma de ângulo aberto
- Glaucoma agudo de ângulo fechado
- Normal – tensão Glaucoma
- Glaucoma Secundário
- Glaucoma Pigmentar
- Glaucoma Congénito
On the basis of glaucoma type, the europe micro invasive glaucoma surgery (migs) devices market is segmented into open angle glaucoma, acute angle closure glaucoma, normal tension glaucoma, secondary glaucoma, pigmentary glaucoma and congenital glaucoma.
End User
- Hospital Outpatient Departments (HOPD)
- Ophthalmology Clinics
- Ambulatory Surgery Centers (ASCS)
- Others
On the basis of end-user, the europe micro invasive glaucoma surgery (MIGS) devices market is segmented into hospital outpatient departments (HOPD), ophthalmology clinics, ambulatory surgery centers (ASCS), and others.
Distribution Channel
- Direct Tender
- Retail Sales
- Others
On the basis of distribution channel, the europe micro invasive glaucoma surgery (MIGS) devices market is segmented into direct tender and retail sales.
Europe Micro Invasive Glaucoma Surgery (MIGS) Devices Market Regional Analysis/Insights
The Europe micro invasive glaucoma surgery (MIGS) devices market is categorized into six segments by product type, target, surgery type, glaucoma type, end user, and distribution channel.
The countries covered in this market report Germany, U.K., France, Italy, Russia, Spain, Turkey, Switzerland, Netherlands, Belgium, Denmark, Poland, Sweden, Norway, Finland and the rest of Europe.
Germany is dominating due to rise in prevalence of glaucoma or other related issues among the population.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impact the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, regulatory acts, and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of regional brands and their challenges faced due to large or scarce competition from local and domestic brands, and impact of sales channels are considered while providing forecast analysis of the country data.
Competitive Landscape and Europe Micro Invasive Glaucoma Surgery (MIGS) Devices Market Share Analysis
Europe micro invasive glaucoma surgery (MIGS) devices market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in R and D, new market initiatives, production sites and facilities, company strengths and weaknesses, product launch, product approvals, product width and breath, application dominance, technology lifeline curve. The above data points provided are only related to the company’s focus on the Europe micro invasive glaucoma surgery (MIGS) devices market.
Alguns dos principais players que operam no mercado europeu de dispositivos de cirurgia microinvasiva do glaucoma (MIGS) são a Glaukos corporation, a AbbVie Inc., a Alcon, a Johnson & Johnson Vision Care Inc., a Sight sciences, Inc., a Santen Pharmaceutical Co., Ltd, iSTAR Medical, BVI, Nova Eye Medical, Lumenis Be Ltd, Inami & Co., Ltd, Oertli Instrumente AG, Lumibird e entre outros.
SKU-
Obtenha acesso online ao relatório sobre a primeira nuvem de inteligência de mercado do mundo
- Painel interativo de análise de dados
- Painel de análise da empresa para oportunidades de elevado potencial de crescimento
- Acesso de analista de pesquisa para personalização e customização. consultas
- Análise da concorrência com painel interativo
- Últimas notícias, atualizações e atualizações Análise de tendências
- Aproveite o poder da análise de benchmark para um rastreio abrangente da concorrência
Índice
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF EUROPE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET
1.4 LIMITATIONS
1.5 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 CURRENCY AND PRICING
2.5 DBMR TRIPOD DATA VALIDATION MODEL
2.6 MULTIVARIATE MODELLING
2.7 PRODUCTS LIFELINE CURVE
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.9 DBMR MARKET POSITION GRID
2.1 MARKET APPLICATION COVERAGE GRID
2.11 VENDOR SHARE ANALYSIS
2.12 SECONDARY SOURCES
2.13 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PRIMIUM INSIGHT
4.1 PESTEL
4.2 PORTER
5 VALUE CHAIN ANALYSIS
6 INDUSTRY INSIGHTS
6.1 MICRO AND MACROECONOMIC FACTORS
6.2 PENETRATION AND GROWTH PROSPECT MAPPING
6.3 KEY PRICING STRATEGIES
7 COST ANALYSIS BREAKDOWN
8 TECHNOLOGY ROADMAP
9 REIMBURSEMENT FRAMEWORK
10 INNOVATION TRACKER AND STRATEGIC ANALYSIS
11 REGULATION
12 MARKET OVERVIEW
12.1 DRIVERS
12.1.1 INCREASE IN THE GERIATRIC POPULATION
12.1.2 RISE IN INCIDENCE OF GLAUCOMA
12.1.3 GROWTH IN THE POPULARITY OF MINIMALLY INVASIVE SURGERY
12.2 RESTRAINTS
12.2.1 INADEQUATE REIMBURSEMENT SCENARIO
12.2.2 STRINGENT REGULATIONS FOR MIGS DEVICES
12.3 OPPORTUNITIES
12.3.1 RAPID TRANSITION FROM GLAUCOMA MEDICATION TO MINIMALLY INVASIVE GLAUCOMA SURGERIES
12.3.2 INTRODUCTION OF TECHNOLOGICAL ADVANCED PRODUCT
12.4 CHALLENGES
12.4.1 LACK OF SKILLED PROFESSIONALS WITH ADEQUATE KNOWLEDGE
12.4.2 RISKS ASSOCIATED WITH MICRO INVASIVE GLAUCOMA SURGERY
13 EUROPE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE
13.1 OVERVIEW
13.2 MIGS STENTS
13.3 MIGS SHUNTS
13.4 TRABECTOME
13.5 KAHOOK DUAL BLADE
13.6 TUBE SHUNT
13.7 MICRO IMPLANTS
13.8 MICRO CATHETERS
13.9 OTHERS
14 EUROPE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY TARGET
14.1 OVERVIEW
14.2 TRABECULAR MESHWORK
14.3 REDUCING AQUEOUS PRODUCTION
14.4 SUPRACHOROIDAL SPACE
14.5 SUBCONJUNCTIVAL FILTRATION
14.6 OTHERS
15 EUROPE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY SURGERY TYPE
15.1 OVERVIEW
15.2 GLAUCOMA IN CONJUNCTION WITH CATARACT
15.3 STAND-ALONE GLAUCOMA
16 EUROPE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY GLAUCOMA TYPE
16.1 OVERVIEW
16.2 OPEN ANGLE GLAUCOMA
16.3 ACUTE ANGLE GLAUCOMA
16.4 NORMAL TENSION GLAUCOMA
16.5 SECONDARY GLAUCOMA
16.6 PIGMENTARY GLAUCOMA
16.7 CONGENITAL GLAUCOMA
17 EUROPE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY END USER
17.1 OVERVIEW
17.2 HOSPITAL OUTPATIENT DEPARTMENT (HOPD)
17.3 OPHTHALMOLOGY CLINICS
17.4 AMBULATORY SURGERY CENTERS (ASCS)
17.5 OTHERS
18 EUROPE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY DISTRIBUTION CHANNEL
18.1 OVERVIEW
18.2 DIRECT TENDER
18.3 RETAIL SALES
18.4 OTHERS
19 EUROPE
19.1 GERMANY
19.2 U.K.
19.3 FRANCE
19.4 ITALY
19.5 RUSSIA
19.6 SPAIN
19.7 TURKEY
19.8 SWITZERLAND
19.9 NETHERLANDS
19.1 BELGIUM
19.11 DENMARK
19.12 POLAND
19.13 SWEDEN
19.14 NORWAY
19.15 FINLAND
19.16 REST OF EUROPE
20 EUROPE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: COMPANY LANDSCAPE
20.1 COMPANY SHARE ANALYSIS: EUROPE
21 SWOT ANALYSIS
22 QUESTIONNAIRE
23 RELATED REPORTS
Lista de Tabela
TABLE 1 EUROPE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 2 EUROPE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY TARGET, 2021-2030 (USD MILLION)
TABLE 3 EUROPE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY SURGERY TYPE, 2021-2030 (USD MILLION)
TABLE 4 EUROPE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 5 EUROPE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 6 EUROPE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY COUNTRY, 2021-2030 (USD MILLION)
TABLE 7 EUROPE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 8 EUROPE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)
TABLE 9 EUROPE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 10 EUROPE MIGS STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 11 EUROPE MIGS STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)
TABLE 12 EUROPE MIGS STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 13 EUROPE I-STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 14 EUROPE I-STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)
TABLE 15 EUROPE I-STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 16 EUROPE TRABECTOME IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 17 EUROPE TRABECTOME IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)
TABLE 18 EUROPE TRABECTOME IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 19 EUROPE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY TARGET, 2021-2030 (USD MILLION)
TABLE 20 EUROPE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY SURGERY TYPE, 2021-2030 (USD MILLION)
TABLE 21 EUROPE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY GLAUCOMA TYPE, 2021-2030 (USD MILLION)
TABLE 22 EUROPE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 23 EUROPE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 24 GERMANY MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 25 GERMANY MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)
TABLE 26 GERMANY MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 27 GERMANY MIGS STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 28 GERMANY MIGS STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)
TABLE 29 GERMANY MIGS STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 30 GERMANY I-STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 31 GERMANY I-STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)
TABLE 32 GERMANY I-STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 33 GERMANY TRABECTOME IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 34 GERMANY TRABECTOME IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)
TABLE 35 GERMANY TRABECTOME IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 36 GERMANY MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY TARGET, 2021-2030 (USD MILLION)
TABLE 37 GERMANY MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY SURGERY TYPE, 2021-2030 (USD MILLION)
TABLE 38 GERMANY MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY GLAUCOMA TYPE, 2021-2030 (USD MILLION)
TABLE 39 GERMANY MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 40 GERMANY MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 41 U.K. MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 42 U.K. MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)
TABLE 43 U.K. MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 44 U.K. MIGS STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 45 U.K. MIGS STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)
TABLE 46 U.K. MIGS STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 47 U.K. I-STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 48 U.K. I-STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)
TABLE 49 U.K. I-STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 50 U.K. TRABECTOME IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 51 U.K. TRABECTOME IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)
TABLE 52 U.K. TRABECTOME IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 53 U.K. MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY TARGET, 2021-2030 (USD MILLION)
TABLE 54 U.K. MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY SURGERY TYPE, 2021-2030 (USD MILLION)
TABLE 55 U.K. MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY GLAUCOMA TYPE, 2021-2030 (USD MILLION)
TABLE 56 U.K. MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 57 U.K. MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 58 FRANCE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 59 FRANCE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)
TABLE 60 FRANCE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 61 FRANCE MIGS STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 62 FRANCE MIGS STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)
TABLE 63 FRANCE MIGS STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 64 FRANCE I-STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 65 FRANCE I-STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)
TABLE 66 FRANCE I-STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 67 FRANCE TRABECTOME IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 68 FRANCE TRABECTOME IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)
TABLE 69 FRANCE TRABECTOME IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 70 FRANCE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY TARGET, 2021-2030 (USD MILLION)
TABLE 71 FRANCE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY SURGERY TYPE, 2021-2030 (USD MILLION)
TABLE 72 FRANCE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY GLAUCOMA TYPE, 2021-2030 (USD MILLION)
TABLE 73 FRANCE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 74 FRANCE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 75 ITALY MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 76 ITALY MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)
TABLE 77 ITALY MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 78 ITALY MIGS STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 79 ITALY MIGS STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)
TABLE 80 ITALY MIGS STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 81 ITALY I-STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 82 ITALY I-STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)
TABLE 83 ITALY I-STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 84 ITALY TRABECTOME IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 85 ITALY TRABECTOME IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)
TABLE 86 ITALY TRABECTOME IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 87 ITALY MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY TARGET, 2021-2030 (USD MILLION)
TABLE 88 ITALY MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY SURGERY TYPE, 2021-2030 (USD MILLION)
TABLE 89 ITALY MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY GLAUCOMA TYPE, 2021-2030 (USD MILLION)
TABLE 90 ITALY MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 91 ITALY MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 92 RUSSIA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 93 RUSSIA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)
TABLE 94 RUSSIA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 95 RUSSIA MIGS STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 96 RUSSIA MIGS STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)
TABLE 97 RUSSIA MIGS STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 98 RUSSIA I-STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 99 RUSSIA I-STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)
TABLE 100 RUSSIA I-STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 101 RUSSIA TRABECTOME IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 102 RUSSIA TRABECTOME IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)
TABLE 103 RUSSIA TRABECTOME IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 104 RUSSIA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY TARGET, 2021-2030 (USD MILLION)
TABLE 105 RUSSIA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY SURGERY TYPE, 2021-2030 (USD MILLION)
TABLE 106 RUSSIA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY GLAUCOMA TYPE, 2021-2030 (USD MILLION)
TABLE 107 RUSSIA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 108 RUSSIA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 109 SPAIN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 110 SPAIN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)
TABLE 111 SPAIN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 112 SPAIN MIGS STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 113 SPAIN MIGS STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)
TABLE 114 SPAIN MIGS STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 115 SPAIN I-STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 116 SPAIN I-STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)
TABLE 117 SPAIN I-STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 118 SPAIN TRABECTOME IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 119 SPAIN TRABECTOME IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)
TABLE 120 SPAIN TRABECTOME IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 121 SPAIN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY TARGET, 2021-2030 (USD MILLION)
TABLE 122 SPAIN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY SURGERY TYPE, 2021-2030 (USD MILLION)
TABLE 123 SPAIN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY GLAUCOMA TYPE, 2021-2030 (USD MILLION)
TABLE 124 SPAIN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 125 SPAIN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 126 TURKEY MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 127 TURKEY MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)
TABLE 128 TURKEY MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 129 TURKEY MIGS STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 130 TURKEY MIGS STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)
TABLE 131 TURKEY MIGS STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 132 TURKEY I-STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 133 TURKEY I-STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)
TABLE 134 TURKEY I-STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 135 TURKEY TRABECTOME IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 136 TURKEY TRABECTOME IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)
TABLE 137 TURKEY TRABECTOME IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 138 TURKEY MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY TARGET, 2021-2030 (USD MILLION)
TABLE 139 TURKEY MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY SURGERY TYPE, 2021-2030 (USD MILLION)
TABLE 140 TURKEY MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY GLAUCOMA TYPE, 2021-2030 (USD MILLION)
TABLE 141 TURKEY MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 142 TURKEY MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 143 SWITZERLAND MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 144 SWITZERLAND MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)
TABLE 145 SWITZERLAND MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 146 SWITZERLAND MIGS STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 147 SWITZERLAND MIGS STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)
TABLE 148 SWITZERLAND MIGS STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 149 SWITZERLAND I-STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 150 SWITZERLAND I-STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)
TABLE 151 SWITZERLAND I-STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 152 SWITZERLAND TRABECTOME IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 153 SWITZERLAND TRABECTOME IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)
TABLE 154 SWITZERLAND TRABECTOME IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 155 SWITZERLAND MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY TARGET, 2021-2030 (USD MILLION)
TABLE 156 SWITZERLAND MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY SURGERY TYPE, 2021-2030 (USD MILLION)
TABLE 157 SWITZERLAND MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY GLAUCOMA TYPE, 2021-2030 (USD MILLION)
TABLE 158 SWITZERLAND MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 159 SWITZERLAND MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 160 NETHERLANDS MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 161 NETHERLANDS MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)
TABLE 162 NETHERLANDS MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 163 NETHERLANDS MIGS STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 164 NETHERLANDS MIGS STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)
TABLE 165 NETHERLANDS MIGS STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 166 NETHERLANDS I-STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 167 NETHERLANDS I-STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)
TABLE 168 NETHERLANDS I-STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 169 NETHERLANDS TRABECTOME IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 170 NETHERLANDS TRABECTOME IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)
TABLE 171 NETHERLANDS TRABECTOME IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 172 NETHERLANDS MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY TARGET, 2021-2030 (USD MILLION)
TABLE 173 NETHERLANDS MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY SURGERY TYPE, 2021-2030 (USD MILLION)
TABLE 174 NETHERLANDS MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY GLAUCOMA TYPE, 2021-2030 (USD MILLION)
TABLE 175 NETHERLANDS MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 176 NETHERLANDS MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 177 BELGIUM MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 178 BELGIUM MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)
TABLE 179 BELGIUM MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 180 BELGIUM MIGS STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 181 BELGIUM MIGS STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)
TABLE 182 BELGIUM MIGS STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 183 BELGIUM I-STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 184 BELGIUM I-STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)
TABLE 185 BELGIUM I-STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 186 BELGIUM TRABECTOME IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 187 BELGIUM TRABECTOME IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)
TABLE 188 BELGIUM TRABECTOME IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 189 BELGIUM MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY TARGET, 2021-2030 (USD MILLION)
TABLE 190 BELGIUM MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY SURGERY TYPE, 2021-2030 (USD MILLION)
TABLE 191 BELGIUM MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY GLAUCOMA TYPE, 2021-2030 (USD MILLION)
TABLE 192 BELGIUM MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 193 BELGIUM MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 194 DENMARK MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 195 DENMARK MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)
TABLE 196 DENMARK MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 197 DENMARK MIGS STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 198 DENMARK MIGS STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)
TABLE 199 DENMARK MIGS STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 200 DENMARK I-STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 201 DENMARK I-STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)
TABLE 202 DENMARK I-STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 203 DENMARK TRABECTOME IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 204 DENMARK TRABECTOME IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)
TABLE 205 DENMARK TRABECTOME IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 206 DENMARK MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY TARGET, 2021-2030 (USD MILLION)
TABLE 207 DENMARK MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY SURGERY TYPE, 2021-2030 (USD MILLION)
TABLE 208 DENMARK MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY GLAUCOMA TYPE, 2021-2030 (USD MILLION)
TABLE 209 DENMARK MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 210 DENMARK MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 211 POLAND MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 212 POLAND MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)
TABLE 213 POLAND MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 214 POLAND MIGS STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 215 POLAND MIGS STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)
TABLE 216 POLAND MIGS STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 217 POLAND I-STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 218 POLAND I-STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)
TABLE 219 POLAND I-STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 220 POLAND TRABECTOME IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 221 POLAND TRABECTOME IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)
TABLE 222 POLAND TRABECTOME IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 223 POLAND MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY TARGET, 2021-2030 (USD MILLION)
TABLE 224 POLAND MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY SURGERY TYPE, 2021-2030 (USD MILLION)
TABLE 225 POLAND MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY GLAUCOMA TYPE, 2021-2030 (USD MILLION)
TABLE 226 POLAND MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 227 POLAND MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 228 SWEDEN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 229 SWEDEN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)
TABLE 230 SWEDEN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 231 SWEDEN MIGS STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 232 SWEDEN MIGS STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)
TABLE 233 SWEDEN MIGS STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 234 SWEDEN I-STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 235 SWEDEN I-STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)
TABLE 236 SWEDEN I-STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 237 SWEDEN TRABECTOME IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 238 SWEDEN TRABECTOME IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)
TABLE 239 SWEDEN TRABECTOME IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 240 SWEDEN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY TARGET, 2021-2030 (USD MILLION)
TABLE 241 SWEDEN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY SURGERY TYPE, 2021-2030 (USD MILLION)
TABLE 242 SWEDEN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY GLAUCOMA TYPE, 2021-2030 (USD MILLION)
TABLE 243 SWEDEN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 244 SWEDEN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 245 NORWAY MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 246 NORWAY MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)
TABLE 247 NORWAY MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 248 NORWAY MIGS STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 249 NORWAY MIGS STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)
TABLE 250 NORWAY MIGS STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 251 NORWAY I-STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 252 NORWAY I-STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)
TABLE 253 NORWAY I-STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 254 NORWAY TRABECTOME IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 255 NORWAY TRABECTOME IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)
TABLE 256 NORWAY TRABECTOME IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 257 NORWAY MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY TARGET, 2021-2030 (USD MILLION)
TABLE 258 NORWAY MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY SURGERY TYPE, 2021-2030 (USD MILLION)
TABLE 259 NORWAY MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY GLAUCOMA TYPE, 2021-2030 (USD MILLION)
TABLE 260 NORWAY MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 261 NORWAY MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 262 FINLAND MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 263 FINLAND MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)
TABLE 264 FINLAND MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 265 FINLAND MIGS STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 266 FINLAND MIGS STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)
TABLE 267 FINLAND MIGS STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 268 FINLAND I-STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 269 FINLAND I-STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)
TABLE 270 FINLAND I-STENT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 271 FINLAND TRABECTOME IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 272 FINLAND TRABECTOME IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME)
TABLE 273 FINLAND TRABECTOME IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (ASP)
TABLE 274 FINLAND MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY TARGET, 2021-2030 (USD MILLION)
TABLE 275 FINLAND MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY SURGERY TYPE, 2021-2030 (USD MILLION)
TABLE 276 FINLAND MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY GLAUCOMA TYPE, 2021-2030 (USD MILLION)
TABLE 277 FINLAND MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 278 FINLAND MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 279 REST OF EUROPE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
Lista de Figura
FIGURE 1 EUROPE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: SEGMENTATION
FIGURE 2 EUROPE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: DATA TRIANGULATION
FIGURE 3 EUROPE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: DROC ANALYSIS
FIGURE 4 EUROPE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: EUROPE VS COUNTRY MARKET ANALYSIS
FIGURE 5 EUROPE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 EUROPE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 7 EUROPE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: DBMR MARKET POSITION GRID
FIGURE 8 EUROPE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: MARKET END USER GRID
FIGURE 9 EUROPE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: VENDOR SHARE ANALYSIS
FIGURE 10 EUROPE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: SEGMENTATION
FIGURE 11 INCREASING GERIATRIC POPULATIONAND RISING PREVALENCE OF GLAUCOMA IS EXPECTED TO DRIVE THE EUROPE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET IN THE FORECAST PERIOD OF 2023 TO 2030
FIGURE 12 PRODUCT TYPE SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE EUROPE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET IN 2023 TO 2030
FIGURE 13 DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES OF EUROPE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET
FIGURE 14 EUROPE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: BY PRODUCT TYPE, 2022
FIGURE 15 EUROPE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: BY PRODUCT TYPE, 2023-2030 (USD MILLION)
FIGURE 16 EUROPE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: BY PRODUCT TYPE, CAGR (2023-2030)
FIGURE 17 EUROPE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: BY PRODUCT TYPE, LIFELINE CURVE
FIGURE 18 EUROPE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: BY TARGET, 2022
FIGURE 19 EUROPE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: BY TARGET, 2023- 2030 (USD MILLION)
FIGURE 20 EUROPE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: BY TARGET, CAGR (2023- 2030)
FIGURE 21 EUROPE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: BY TARGET, LIFELINE CURVE
FIGURE 22 EUROPE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: BY SURGERY TYPE, 2022
FIGURE 23 EUROPE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: BY SURGERY TYPE, 2023-2030 (USD MILLION)
FIGURE 24 EUROPE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: BY SURGERY TYPE, CAGR (2023-2030)
FIGURE 25 EUROPE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: BY SURGERY TYPE, LIFELINE CURVE
FIGURE 26 EUROPE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: BY GLAUCOMA TYPE, 2022
FIGURE 27 EUROPE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: BY GLAUCOMA TYPE, 2023-2030 (USD MILLION)
FIGURE 28 EUROPE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: BY GLAUCOMA TYPE, CAGR (2023-2030)
FIGURE 29 EUROPE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: BY GLAUCOMA TYPE, LIFELINE CURVE
FIGURE 30 EUROPE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: BY END USER, 2022
FIGURE 31 EUROPE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: BY END USER, 2023-2030 (USD MILLION)
FIGURE 32 EUROPE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: BY END USER, CAGR (2023- 2030)
FIGURE 33 EUROPE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: BY END USER, LIFELINE CURVE
FIGURE 34 EUROPE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: BY DISTRIBUTION CHANNEL, 2022
FIGURE 35 EUROPE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: BY DISTRIBUTION CHANNEL, 2023-2030 (USD MILLION)
FIGURE 36 EUROPE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: BY DISTRIBUTION CHANNEL, CAGR (2023-2030)
FIGURE 37 EUROPE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE
FIGURE 38 EUROPE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: SNAPSHOT (2022)
FIGURE 39 EUROPE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: COMPANY SHARE 2022 (%)
Metodologia de Investigação
A recolha de dados e a análise do ano base são feitas através de módulos de recolha de dados com amostras grandes. A etapa inclui a obtenção de informações de mercado ou dados relacionados através de diversas fontes e estratégias. Inclui examinar e planear antecipadamente todos os dados adquiridos no passado. Da mesma forma, envolve o exame de inconsistências de informação observadas em diferentes fontes de informação. Os dados de mercado são analisados e estimados utilizando modelos estatísticos e coerentes de mercado. Além disso, a análise da quota de mercado e a análise das principais tendências são os principais fatores de sucesso no relatório de mercado. Para saber mais, solicite uma chamada de analista ou abra a sua consulta.
A principal metodologia de investigação utilizada pela equipa de investigação do DBMR é a triangulação de dados que envolve a mineração de dados, a análise do impacto das variáveis de dados no mercado e a validação primária (especialista do setor). Os modelos de dados incluem grelha de posicionamento de fornecedores, análise da linha de tempo do mercado, visão geral e guia de mercado, grelha de posicionamento da empresa, análise de patentes, análise de preços, análise da quota de mercado da empresa, normas de medição, análise global versus regional e de participação dos fornecedores. Para saber mais sobre a metodologia de investigação, faça uma consulta para falar com os nossos especialistas do setor.
Personalização disponível
A Data Bridge Market Research é líder em investigação formativa avançada. Orgulhamo-nos de servir os nossos clientes novos e existentes com dados e análises que correspondem e atendem aos seus objetivos. O relatório pode ser personalizado para incluir análise de tendências de preços de marcas-alvo, compreensão do mercado para países adicionais (solicite a lista de países), dados de resultados de ensaios clínicos, revisão de literatura, mercado remodelado e análise de base de produtos . A análise de mercado dos concorrentes-alvo pode ser analisada desde análises baseadas em tecnologia até estratégias de carteira de mercado. Podemos adicionar quantos concorrentes necessitar de dados no formato e estilo de dados que procura. A nossa equipa de analistas também pode fornecer dados em tabelas dinâmicas de ficheiros Excel em bruto (livro de factos) ou pode ajudá-lo a criar apresentações a partir dos conjuntos de dados disponíveis no relatório.
